Home › Sjögren's Disease › Massachusetts
Sjögren's Disease clinical trials in Massachusetts
5 studies for Sjögren's Disease are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345The Myelin Disorders Biorepository Project
- Massachusetts General Hospital (MGH), Boston
RecruitingObservational study
All ages · All sexes · Updated Nov 12, 2026 · NCT03047369Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Tufts Medical Center, Boston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07621809Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Tufts Medical Center, Boston
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07404865A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Tufts University School of Dental Medicine, Boston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT06747949From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.